Comprehensive Money Management Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Comprehensive Money Management Services’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$299K	Hold	5,266	–	–	0.19%	156
2026 Q1	$230K	Hold	5,266	–	–	0.15%	175
2025 Q4	$239K	Buy	5,266 +25	+0.5%	+$1.11K	0.17%	173
2025 Q3	$204K	Buy	5,241 +115	+2%	+$4.17K	0.14%	180
2025 Q2	$173K	Buy	5,126 +37	+0.7%	+$1.17K	0.13%	178
2025 Q1	$162K	Buy	5,089 +500	+11%	+$19K	0.13%	174
2024 Q4	$178K	Buy	+4,589	New	+$193K	0.15%	172

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

AAP

Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

FIA

Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return

Comprehensive Money Management Services's GNOM Position: Q2 2026 in Review

Comprehensive Money Management Services held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2026 at 5,266 shares worth $299K. The position accounts for 0.19% of the portfolio, ranked #156.

Comprehensive Money Management Services first reported a position in GNOM in Q4 2024 and has held it in 7 quarters since. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

Comprehensive Money Management Services held 5,266 shares of Global X Genomics & Biotechnology ETF worth $299K as of Q2 2026.
Comprehensive Money Management Services left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2026.
Global X Genomics & Biotechnology ETF made up 0.19% of Comprehensive Money Management Services's portfolio in Q2 2026, its #156 holding.
Comprehensive Money Management Services first reported a position in Global X Genomics & Biotechnology ETF in Q4 2024 and has held it in 7 quarters since.
48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Comprehensive Money Management Services's 13F filing for Q2 2026, filed 17 Aug 2026.